Advertisement
Advertisement

CGEN

CGEN logo

Compugen Ltd

2.41
USD
Sponsored
+0.11
+4.78%
Aug 07, 15:59 UTC -4
Closed
exchange

After-Market

2.38

-0.04
-1.45%

Compugen Ltd Profile

About

Compugen Ltd. is a pioneer in the fields of computational genomics and proteomics. The company combines the disciplines of mathematics and computer science with molecular biology to improve the understanding of genomics and proteomics, the study of genes and proteins. Compugen's expertise in these areas is used to develop core technologies and platforms that are the basis for its products and services. These products and services are designed to enable life scientists to significantly enhance their research efforts in drug discovery.

Info & Links

CEO

Eran Ophir

Headquarters

Azrieli Center, 26 Harokmim Street, Building D
Holon, L3 5885849, ISRAEL

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.cgen.com

Auditor

KOST FORER GABBAY & KASIERER

Share holders

33

Employees

75

Compugen Ltd Statistics

Valuation Measures

Market Capitalization2

224.64M

Enterprise Value

214.36M

Enterprise Value/EBITDA(ttm)

7.08

Price to Earnings Ratio(ttm)

6.34

Price to Sales(ttm)

3.08

Price to Book(mrq)

2.57

Price to Cash(ytd)

6.45

Profitability

Gross Margin(ttm)

30.03%

Operating Margin(ttm)

47.56%

Profit Margin(ttm)

-226.58%

Return on Equity(ttm)

42.57%

Return on Invested Capital(ttm)

23.47%

Return on Assets(ttm)

26.13%

Income Statement

Revenue(ttm)

74.00M

Revenue Per Share(ttm)

--

Gross Profit(ttm)

64.30M

EBITDA(ttm)3

30.30M

Net Income Available to Common(ttm)

35.19M

Diluted EPS(ttm)

0.38

Share Statistics

Beta (5Y Monthly)

2.77

52-Week Change

60.67%

S&P 500 52-Week Change

21.72%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

--

Dividend Yield

0.00%

Float4

85.57M

% Held by Insiders

9.50%

% Held by Institutions

12.22%

Balance Sheet

Total Cash(mrq)

125.30M

Total Cash Per Share(mrq)

--

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

5.72%

Quick Ratio(mrq)

6.23%

Book Value Per Share(mrq)

0.94

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.23

Free Cash Flow(ytd)

-21.98M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement